戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              Ebstein anomaly and tricuspid valve dysplasia are rare c
2                                              Ebstein anomaly is a spectrum of tricuspid valvular and
3                                              Ebstein's anomaly and other tricuspid valve abnormalitie
4                                              Ebstein's anomaly was diagnosed in one lithium-exposed f
5                                              Ebstein's malformation coexisted in 18 patients.
6  25%), tricuspid atresia (12 patients, 20%), Ebstein's anomaly (4 patients, 6.5%), pulmonic atresia o
7 trial to right ventricle bioprosthesis in 3, Ebstein's anomaly of the TV in 5, and other in 6), and 2
8 dum atrial septal defect (ASD) (n = 71), and Ebstein's malformation (n = 7) for NKX2.5 mutations.
9 orrected transposition of great arteries and Ebstein anomaly of the tricuspid valve.
10  in human congenital heart diseases, such as Ebstein's anomaly.
11 irst report of individuals being affected by Ebstein anomaly because of a mutation in this gene and d
12  adults with congenital heart disease (CHD): Ebstein's anomaly, the failing Fontan, and pulmonary val
13 , including atrioventricular septal defects, Ebstein malformation of the tricuspid valve, and perimem
14 apy of tricuspid valve anomalies, especially Ebstein's malformation.
15 tricular septal defect, tetralogy of Fallot, Ebstein anomaly, transposition of the great vessels, and
16                                     Familial Ebstein anomaly is a rare form of congenital heart disea
17                     Definitive operation for Ebstein's anomaly results in improved exercise tolerance
18 tional outcomes after undergoing surgery for Ebstein anomaly.
19                                  Surgery for Ebstein's anomaly can now be offered to older patients a
20 performed on adults with CHD are surgery for Ebstein's anomaly, Fontan revision, and pulmonary valve
21 mmunosuppression with anti-viral therapy for Ebstein-Barr virus (EBV) is the primary treatment for al
22 sed risk of cardiac malformations, including Ebstein's anomaly; the magnitude of this effect was smal
23 ciated with a marked increase in the risk of Ebstein's anomaly (a right ventricular outflow tract obs
24   The classification of clinical severity of Ebstein anomaly still remains a challenge.
25 imaging measure for the clinical severity of Ebstein anomaly.
26 rofound cardiogenic shock caused by a severe Ebstein anomaly can be successfully salvaged with fenest
27   Stereotactic biopsy confirmed PCNSL due to Ebstein-Barr virus reactivation.
28  a mean age of 26+/-14 years with unrepaired Ebstein anomaly were examined in a prospective study.
29     The most frequent cardiac diagnoses were Ebstein's anomaly (40%), pulmonary atresia (11%), and te
30 utcomes in patients >/= 50 years of age with Ebstein anomaly (EA).
31                       Fetuses diagnosed with Ebstein anomaly and tricuspid valve dysplasia from 2005
32 viduals among 2 generations of 1 family with Ebstein anomaly.
33 s large, contemporary series of fetuses with Ebstein anomaly and tricuspid valve dysplasia, perinatal
34 e with severe tetralogy of Fallot, four with Ebstein's anomaly and two with single ventricle and pulm
35  1972, to January 1, 2006, 539 patients with Ebstein anomaly underwent 604 cardiac operations at the
36 ong-term functional outcome of patients with Ebstein anomaly who had cardiac operation at our institu
37                             In patients with Ebstein anomaly, the easily acquired index of right-side
38                                Patients with Ebstein's anomaly of the tricuspid valve may have exerci
39 nants of exercise tolerance in patients with Ebstein's anomaly.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。